GT Biopharma
Symbol: GTBP

James Dale Davidson of Strategic Investment Rating:


Now is the Time to Buy

My top pick, GT Biopharma (GTBP), is pulling out all the stops to bring this exciting new therapy to cancer patients across the U.S. and around the world. .

What YOU Should Consider Now

  • Go online or call your discount broker to invest in GT Biopharma, Inc (GTBP)
  • Subscribe now to Strategic Investment 

Are you ready to invest in GTBP?

GT Biopharma  is available for purchase with all Brokerage Firms, such as but not limited to:


Spread the Word

Hot Stock Alert GTBP

Click to Tweet

IMPORTANT NOTICE AND DISCLAIMER: All investments are subject to risk, which must be considered on an individual basis before making any investment decision.  Strategic Investment is the publisher of these materials and is not responsible for errors and omissions. This publication is intended solely for information and educational purposes and is not to be construed, under any circumstances, as an offer to buy or sell, or a solicitation to buy or sell or trade, or as a personal recommendation to buy or sell or trade in any securities or commodities named within these materials.  These materials are a paid advertisement. Information gathered to create these materials is from sources believed to be reliable but is in no way guaranteed. Furthermore, you cannot be assured that you will profit or that any losses can or will be limited. It is important to know that no guarantee of any kind is implied or possible where projections of future conditions in the markets are attempted. Hypothetical or simulated performance results have certain inherent limitations as to liquidity and execution, among other variables. All readers should consult their own personal investment adviser before making an investment decision. Investing in securities is highly speculative and carries a great deal of risk, especially as to newer companies with comparatively short operating histories and limited earnings.  This report contains projections regarding future operating results, which are forward-looking statements. Those projections were derived from sources that have not been verified independently. All forward-looking statements are believed to have a reasonable basis, but are subject to risks, uncertainties and other factors that could cause actual results to differ materially from future results expressed, projected or implied by such forward-looking statements. Those projections should not be considered a comprehensive representation of the featured company’s future performance. Strategic Investment is a paid circulation newsletter and is not a financial analyst, investment advisor or broker/dealer. These materials are a solicitation for subscriptions for the newsletter and a paid promotional advertisement of GTBiopharma, Inc (OTC: GTBP).  Strategic Investment expects to generate new subscriber revenue as a result of this advertisement. This paid advertisement includes a stock profile of GTBiopharma, Inc (GTBP). Strategic Investment assumes no obligation to provide any future views in support of the highlighted company. In an effort to enhance public awareness of GTBiopharma, Inc (GTBP) and its securities, provided third-party advertising agencies with a total campaign budget of approximately two million sixty-three thousand six hundred and thirty-four dollars to date to cover the costs associated with creating, printing and distribution of this advertisement and other elements of this campaign in an effort to build investor awareness. Strategic Investment was paid thirty thousand dollars as a research fee. In addition, Strategic Investment may generate new subscription revenue, the amount of which is unknown at this time, as a result of the distribution of these materials. The advertising agencies involved in the campaign relied on information provided by GTBiopharma, Inc (GTBP) and Strategic Investment.  The advertising agencies will retain as their compensation any excess sums remaining in the total campaign budget after all expenses are paid. Readers should take this into consideration in evaluating the statements in these advertising materials. If successful, this advertisement will increase investor and market awareness, which may result in increased numbers of shareholders owning and trading the securities of GTBiopharma, Inc (GTBP), increased trading volumes, and possibly increased share price of the company’s securities. This advertisement, the advertising agencies and Strategic Investment do not purport to provide an analysis of any company’s financial position, operations or prospects, and this is not to be construed as a recommendation by GTBiopharma, Inc (GTBP) or as an offer to buy or sell any security or as investment advice. An offer to buy or sell can only be made with accompanying disclosure documents and only in states and provinces for which they are approved. They are not, and do not purport to be, broker-dealers or registered investment advisors. This advertisement is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the advertised company’s SEC filings. Investing in securities, particularly micro-cap securities such as GTBiopharma, Inc (GTBP), is inherently speculative and carries a high degree of risk. Past performance does not guarantee future results. This advertisement is based exclusively on information generally available to the public and does not contain any non-public information. The information on which it is based is believed to be reliable. Nevertheless, the advertising agencies and Strategic Investment cannot guarantee the accuracy or completeness of the information. The advertising agencies and Strategic Investment note that statements contained herein that look forward in time, which include everything other than historical information, involve risks and uncertainties that may affect the company’s actual results of operations. Factors that could cause actual results to differ include the size and growth of the market for the company’s products and services, the company’s ability to fund its capital requirements in the near term and long term, pricing pressures, etc. Strategic Investment is the publisher’s trademark. All trademarks used in this advertisement other than Strategic Investment are the property of their respective trademark holders and no endorsement by such owners of the contents of these materials is made or implied. The advertising agencies and Strategic Investment are not affiliated, connected, or associated with, and are not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made by them to any rights in any third-party trademarks. More information can be found on the GTBiopharma, Inc website at (www.GTBiopharma.com).   As with any low-priced stock, investors should use only risk capital they are willing to lose or hold for long-term investing.